| ［1］ |
Song B, Shiromoto Y, Minakuchi M, et al. The role of RNA editing enzyme ADAR1 in human disease［J］. Wiley Interdiscip Rev RNA, 2022,13（1）:e1665. doi: 10.1002/wrna.1665.
|
| ［2］ |
Liu Y, Xiao SX, Peng ZH, et al. Two frameshift mutations of the double⁃stranded RNA⁃specific adenosine deaminase gene in Chinese pedigrees with dyschromatosis symmetrica hereditaria［J］. Br J Dermatol, 2006,155（2）:473⁃476. doi: 10.1111/j.1365⁃2133.2006.07223.x.
|
| ［3］ |
Kono M, Akiyama M. Dyschromatosis symmetrica hereditaria and reticulate acropigmentation of Kitamura: an update［J］. J Dermatol Sci, 2019,93（2）:75⁃81. doi: 10.1016/j.jdermsci.2019.01.004.
|
| ［4］ |
Bradford PT, Goldstein AM, Tamura D, et al. Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow⁃up characterises the role of DNA repair［J］. J Med Genet, 2011,48（3）:168⁃176. doi: 10.1136/jmg.2010.083022.
|
| ［5］ |
Lehmann AR, McGibbon D, Stefanini M. Xeroderma pigmentosum［J］. Orphanet J Rare Dis, 2011,6:70. doi: 10.1186/1750⁃1172⁃6⁃70.
|
| ［6］ |
Weon JL, Glass DA 2nd. Novel therapeutic approaches to xeroderma pigmentosum［J］. Br J Dermatol, 2019,181（2）:249⁃255. doi: 10.1111/bjd.17253.
|
| ［7］ |
Pan Y, Zhong W, Wang H, et al. Reticulate acropigmentation of Kitamura with a novel mutation in ADAM10［J］. Clin Exp Dermatol, 2019,44（6）:700⁃703. doi: 10.1111/ced.13832.
|
| ［8］ |
Al Hawsawi K, Al Aboud K, Ramesh V, et al. Dyschromatosis universalis hereditaria: report of a case and review of the literature［J］. Pediatr Dermatol, 2002,19（6）:523⁃526. doi: 10. 1046/j.1525⁃1470.2002.00225.x.
|
| ［9］ |
Urabe K, Hori Y. Dyschromatosis［J］. Semin Cutan Med Surg, 1997,16（1）:81⁃85. doi: 10.1016/s1085⁃5629（97）80039⁃9.
|
